ALZAMEND NEURO, INC. (ALZN) Operating cash flow 2020–2026
ALZAMEND NEURO, INC. (ALZN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.1MFY2026 · since FY2020: -$2.3M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$8.1M | -22.8% |
| FY2025 | -$6.6M | +20.6% |
| FY2024 | -$8.3M | +7.3% |
| FY2023 | -$8.9M | -34.9% |
| FY2022 | -$6.6M | -143.9% |
| FY2021 | -$2.7M | -15.6% |
| FY2020 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice